These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 10626191)

  • 1. Interferon retreatment of patients with chronic hepatitis C. A long-term follow-up.
    Spadaro A; Freni MA; Ajello A; Alessi N; Barbaro E; Resta ML; Ferraü O
    Hepatogastroenterology; 1999; 46(30):3229-33. PubMed ID: 10626191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon retreatment in chronic hepatitis C: which patients to choose, and what schedule to use.
    Picciotto A; Campo N; Brizzolara R; Sinelli N; Torre F; Cipriani AG; Ponassi I; Varagona G; Grasso A; De Leo P; De Conca V; Mesiti S; Marenco G; Menardo G; Dodero M; Celle G
    Eur J Gastroenterol Hepatol; 1999 Jun; 11(6):649-53. PubMed ID: 10418937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre study.
    Ascione A; De Luca M; Canestrini C; Di Costanzo GG; Raimondo G; Longo G; Manns MP; Tillmann HL; Forte GB; Rocco P; Biceglia O; Faleo D; Vinelli F; Cela EM; Amitrano L; Addario L; Gigliotti T
    Ital J Gastroenterol Hepatol; 1998 Oct; 30(5):517-23. PubMed ID: 9836109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical outcome after beta-interferon therapy in cirrhotic patients with chronic hepatitis C. TVVH Study Group.
    Bernardinello E; Cavalletto L; Chemello L; Mezzocolli I; Donada C; Benvegnú L; Merkel C; Gatta A; Alberti A
    Hepatogastroenterology; 1999; 46(30):3216-22. PubMed ID: 10626189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of patients with HCV infection poorly tolerant to recombinant interferon alpha.
    Cagnoni C; Pancotti D; Carrara G
    Hepatogastroenterology; 2000; 47(31):199-203. PubMed ID: 10690609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of chronic hepatitis C in patients treated with interferon: comparison between responders and non-responders.
    Morisco F; Marmo R; Iasevoli P; Sessa G; Tuccillo C; Del Vecchio Blanco C; Caporaso N
    Ital J Gastroenterol Hepatol; 1999; 31(6):454-8. PubMed ID: 10575561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
    Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C.
    Laghi V; Toccaceli F; Rosati S; Monini A; Grimaldi M; Foglianti G; Canova N; Palazzini E
    Hepatogastroenterology; 1997; 44(16):1182-6. PubMed ID: 9261621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.
    Nakamura H; Ogawa H; Kuroda T; Yamamoto M; Enomoto H; Kishima Y; Yoshida K; Ito H; Matsuda M; Noguchi S
    Hepatogastroenterology; 2002; 49(47):1373-6. PubMed ID: 12239945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The retreatment with natural leukocyte interferon alfa-n3 of chronic hepatitis C patients: the intolerant and nonresponsive results to prior treatment with recombinant alfa interferon].
    Cagnoni C; Pancotti D; Carrara G
    Ann Ital Med Int; 1999; 14(3):159-65. PubMed ID: 10566181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.
    Di Bisceglie AM; Thompson J; Smith-Wilkaitis N; Brunt EM; Bacon BR
    Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy.
    Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Suzuki F; Akuta N; Someya T; Hosaka T; Kobayashi M; Kumada H
    J Gastroenterol; 2004; 39(5):455-60. PubMed ID: 15175944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response.
    Espinosa M; Rodriguez M; Martin-Malo A; Alvarez de Lara MA; Gonzalez R; Lopez-Rubio F; de la Mata M; Aljama P
    Clin Nephrol; 2001 Mar; 55(3):220-6. PubMed ID: 11316242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.
    Uyama H; Enomoto H; Kishima Y; Yamamoto M; Yoshida K; Okuda Y; Hirotani T; Kuroda T; Ito H; Matsuda M; Terabayashi M; Noguchi S; Kawase I; Nakamura H
    Hepatogastroenterology; 2003; 50(54):2112-6. PubMed ID: 14696476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porphyria cutanea tarda as a predictor of poor response to interferon alfa therapy in chronic hepatitis C.
    Fernández I; Castellano G; de Salamanca RE; Colina F; Gómez de la Cámara A; Morán MJ; Muñoz R; Solís-Herruzo JA
    Scand J Gastroenterol; 2003 Mar; 38(3):314-9. PubMed ID: 12737448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hepatitis C: interferon retreatment of relapsers. A meta-analysis of individual patient data. European Concerted Action on Viral Hepatitis (EUROHEP).
    Cammà C; Giunta M; Chemello L; Alberti A; Toyoda H; Trepo C; Marcellin P; Zahm F; Schalm S; Craxì A
    Hepatology; 1999 Sep; 30(3):801-7. PubMed ID: 10462389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily interferon therapy for chronic hepatitis C: a report of a community practice experience.
    Srinivas D; Mani H; Crumpler C; Van Thiel DH
    Hepatogastroenterology; 2002; 49(46):1053-7. PubMed ID: 12143200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy.
    Annicchiarico BE; Siciliano M; Avolio AW; Grillo RL; Bombardieri G
    Aliment Pharmacol Ther; 2007 May; 25(9):1039-46. PubMed ID: 17439504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.